Compare GENC & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GENC | FOCL |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 254.2M | 222.4M |
| IPO Year | 1995 | 1998 |
| Metric | GENC | FOCL |
|---|---|---|
| Price | $17.76 | $4.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $21.00 | $8.80 |
| AVG Volume (30 Days) | 51.1K | ★ 70.9K |
| Earning Date | 08-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.08 | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | $48,943,000.00 | ★ $70,527,000.00 |
| Revenue This Year | $1.78 | N/A |
| Revenue Next Year | $25.68 | $34.10 |
| P/E Ratio | $19.92 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $12.22 | $3.99 |
| 52 Week High | $20.19 | $6.40 |
| Indicator | GENC | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 50.92 | 43.56 |
| Support Level | $14.30 | $4.01 |
| Resistance Level | $18.18 | $4.63 |
| Average True Range (ATR) | 0.56 | 0.27 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 61.62 | 18.02 |
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.